NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

It's clear now that PFS will NOT be evaluated by the old criteria... but instead by the new criteria.

Yup, run the trial then redefine the primary endpoint so it is not obvious it has already failed.

You do realize that if they can redefine the endpoint they can obviously make the drug "work", right? Just toss in a criterion like the immune system is improving based on any maker that corrolates with DCVax-L. presto.

On another subject, I have not heard any comments that the blended mOS came in lower than all projections other an AVI77 who nailed it. Does anybody still really think they are going to get some approval on blended results that are not all that impressive? Is that theory now officially dead?